MS MASTERS podcast

New Guidelines for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: Rethinking Hematopoietic Stem Cell Transplantation

2025-08-25
0:00
12:25
Spola tillbaka 15 sekunder
Spola framåt 15 sekunder
Jeffrey Cohen, MD, Professor, Cleveland Clinic Lerner College of Medicine, and Director of the Experimental Therapeutics Program at the Mellen Center for Multiple Sclerosis Treatment and Research at Cleveland Clinic, Cleveland, OH, reviews the latest international guidelines from the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and EBMT on the use of autologous hematopoietic stem cell transplantation (AHSCT) in relapsing multiple sclerosis and neuromyelitis optica spectrum disorder.

Fler avsnitt från "MS MASTERS"